Egis Gyogyszergyar RT.
Records under this name other than the patents Egis Gyogyszergyar RT. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Back to Egis Gyogyszergyar RT.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,415,792 | Blarcamesine co-crystals for the manufacture of pharmaceutical dosage form Held by another company In force · Medium confidence | In force | Medium confidence | |
| US 7,141,604 | Citalopram for the treatment of elevated blood pressure Formerly held Term ended Term ended Mar 13, 2023 · USPTO record | Term ended | Term ended Mar 13, 2023 | USPTO record |
| US 8,778,932 | Dihydro-Oxazolobenzodiazepinone Compounds, a Process for There Preparation and Pharmaceutical Compositions Containing Them Lapsed on the fee record Ended Jul 15, 2022 · High confidence | Lapsed on the fee record | Ended Jul 15, 2022 | High confidence |
| US 6,335,469 | High purity (1R,2S,4R)-(-)-2-[(2′-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof Term ended Term ended May 10, 2020 · USPTO record | Term ended | Term ended May 10, 2020 | USPTO record |
| US 6,624,201 | High Purity (1R,2S,4R)-(−)-2-[(2′-{N,N-DIMETHYLAMINO}-ETHOXY)]-2-[PHENYL]-1,7,7 -Tri-[methyl]-Bicyclo [2.2.1]HEPTANE and Pharmaceutically Acceptable Acid Addition Salts Thereof and a Process for the Preparation of These Compounds as Well as Medicaments Containing 1 or More of These Compounds and Their Use Term ended Ended no later than May 10, 2020 · USPTO record | Term ended | Ended no later than May 10, 2020 | USPTO record |
| US 7,307,168 | Process for the preparation of 3-{2-′4- (6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyllethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido′1,2-methyl-4h-pyrido′,2-a!pyrimidin-4-one Lapsed on the fee record Ended Dec 11, 2019 · USPTO record | Lapsed on the fee record | Ended Dec 11, 2019 | USPTO record |
| US 7,189,711 | 2, 3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient Lapsed on the fee record Ended Mar 13, 2019 · USPTO record | Lapsed on the fee record | Ended Mar 13, 2019 | USPTO record |
| US 7,186,848 | Polymorphs of a 1-pyrrole derivative, intermediate for the preparation of atorvastatin Lapsed on the fee record Ended Mar 6, 2019 · USPTO record | Lapsed on the fee record | Ended Mar 6, 2019 | USPTO record |
| US 7,098,210 | 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient Lapsed on the fee record Ended Aug 29, 2018 · USPTO record | Lapsed on the fee record | Ended Aug 29, 2018 | USPTO record |
| US 6,908,999 | Process for the preparation of {2-[4-α-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxy} acetic acid and novel intermediates therefor Lapsed on the fee record Ended Jun 21, 2017 · USPTO record | Lapsed on the fee record | Ended Jun 21, 2017 | USPTO record |